Patent details

EP1353699 Title: Beta-cyclodextrin-drospirenone inclusion complexes

Basic Information

Publication number:
EP1353699
PCT Application Number:
PCT/IB/2001/002604
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP012712303
PCT Publication Number:
WO/2002/049674
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Beta-cyclodextrin-drospirenone inclusion complexes
French Title of Invention:
Complexes d'inclusion béta-cyclodextrine-drospirenone
German Title of Invention:
Einschlusskomplexe von Drospirenone und Beta-Cyclodextrin
SPC Number:

Dates

Filing date:
20/12/2001
Grant date:
01/02/2012
EP Publication Date:
01/02/2012
PCT Publication Date:
27/06/2002
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
22/10/2003
EP B1 Publication Date:
01/02/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
20/12/2012
Expiration date:
20/12/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/12/2001
 
 

Name:
Bayer Pharma Aktiengesellschaft
Address:
Müllerstrasse 178, 13353 Berlin, Germany (DE)

Inventor

1

Name:
HEIL Wolfgang
Address:
Germany (DE)

2

Name:
BACKENSFELD Thomas
Address:
Germany (DE)

Priority

1

Priority Number:
256483 P
Priority Date:
20/12/2000
Priority Country:
United States (US)

2

Priority Number:
00610134
Priority Date:
20/12/2000
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
A61K 47/48;
Filing date Document type Number of pages